Address
Novo Ventures (US) Inc
1700 Owens Street
Suite 540
San Francisco, CA 94158
United States
Website
Recent investment activity
KANDO id: 36394
Corporate information
Registration country
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 11 of 11Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Alder Biopharmaceuticals Inc | Developer of antibody therapeutics. | N/A | ||||
Cell Biosciences Inc | N/A | |||||
Elevation Pharmaceuticals Inc | Series B | |||||
FoldRx Pharmaceuticals Inc | N/A | |||||
HTG Molecular Diagnostics Inc | N/A | |||||
Metabolex Inc | Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. | N/A | ||||
Metabolex Inc | Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. | Series D | ||||
Otonomy Inc | A biopharmaceutical company, engages in the development and commercialization of treatments for diseases of the inner and middle ear. | N/A | ||||
ProteinSimple | ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. | Series B | ||||
ActivX Biosciences Inc | Discoverer and developer of highly selective, best in class, small molecule drugs for major unmet medical needs. | N/A | ||||
Neomend Inc | A biomedical device company, engages in the development and commercialization of surgical wound healing products | Series D |